These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26699825)

  • 21. [Does dual antiplatelet therapy always require gastroprotection? Tailored medical therapy should prevail over the generalized prescription of proton pump inhibitors in patients on dual antiplatelet therapy].
    Marcucci R
    G Ital Cardiol (Rome); 2010 Jun; 11(6):481-7; discussion 487. PubMed ID: 20922874
    [No Abstract]   [Full Text] [Related]  

  • 22. Risk factors for gastrointestinal bleeding associated with low-dose aspirin.
    Valkhoff VE; Sturkenboom MC; Kuipers EJ
    Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):125-40. PubMed ID: 22542151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database.
    Costarino AT; Dai D; Feng R; Feudtner C; Guevara JP
    Pediatr Crit Care Med; 2015 Sep; 16(7):605-12. PubMed ID: 25901549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic use of gastro-protective agents in patients on low-dose aspirin.
    Balakrishnan S; Jhaj R
    Br J Clin Pharmacol; 2008 Apr; 65(4):621-2. PubMed ID: 18294325
    [No Abstract]   [Full Text] [Related]  

  • 25. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
    MacLaren R; Reynolds PM; Allen RR
    JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Japan aims toward appropriate concomitant use of antiplatelets and antisecretory agents?
    Fujishiro M
    Intern Med; 2009; 48(21):1845-6. PubMed ID: 19881231
    [No Abstract]   [Full Text] [Related]  

  • 27. Difference between the frequencies of antisecretory drug prescriptions in users of buffered vs. enteric-coated low-dose aspirin therapies.
    Hachiken H; Murai A; Wada K; Kuwahara T; Hosomi K; Takada M
    Int J Clin Pharmacol Ther; 2013 Oct; 51(10):807-15. PubMed ID: 24040850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
    Chandrasekhar J; Bansilal S; Baber U; Sartori S; Aquino M; Farhan S; Vogel B; Faggioni M; Giustino G; Ariti C; Colombo A; Chieffo A; Kini A; Saporito R; Michael Gibson C; Witzenbichler B; Cohen D; Moliterno D; Stuckey T; Henry T; Pocock S; Dangas G; Gabriel Steg P; Mehran R
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):E217-E225. PubMed ID: 27650638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The short-term medical management of non-variceal upper gastrointestinal bleeding.
    Kovacs TO; Jensen DM
    Drugs; 2008; 68(15):2105-11. PubMed ID: 18840002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial.
    Sung JJ; Lau JY; Ching JY; Wu JC; Lee YT; Chiu PW; Leung VK; Wong VW; Chan FK
    Ann Intern Med; 2010 Jan; 152(1):1-9. PubMed ID: 19949136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastroprotection in low-dose aspirin users for primary and secondary prevention of ACS: results of a cost-effectiveness analysis including compliance.
    de Groot NL; van Haalen HG; Spiegel BM; Laine L; Lanas A; Focks JJ; Siersema PD; van Oijen MG
    Cardiovasc Drugs Ther; 2013 Aug; 27(4):341-57. PubMed ID: 23417566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastric Acid Suppression-More Data, Less Answers.
    Tofil NM; Prabhakaran P
    Pediatr Crit Care Med; 2015 Sep; 16(7):671-2. PubMed ID: 26335114
    [No Abstract]   [Full Text] [Related]  

  • 33. High-dose pre-endoscopic intravenous proton pump inhibitors in upper gastrointestinal bleeding: Utility or futility?
    Primignani M; Tosetti G
    Dig Liver Dis; 2021 Mar; 53(3):387-388. PubMed ID: 33414085
    [No Abstract]   [Full Text] [Related]  

  • 34. Reply to: High-dose pre-endoscopic intravenous proton pump inhibitors in upper gastrointestinal bleeding: utility or futility?
    Marmo R; Soncini M; Bucci C; Zullo A
    Dig Liver Dis; 2021 Mar; 53(3):389. PubMed ID: 33472768
    [No Abstract]   [Full Text] [Related]  

  • 35. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
    Abraham NS; Hlatky MA; Antman EM; Bhatt DL; Bjorkman DJ; Clark CB; Furberg CD; Johnson DA; Kahi CJ; Laine L; Mahaffey KW; Quigley EM; Scheiman J; Sperling LS; Tomaselli GF;
    Am J Gastroenterol; 2010 Dec; 105(12):2533-49. PubMed ID: 21131924
    [No Abstract]   [Full Text] [Related]  

  • 36. Proton-pump inhibitors can decrease gastrointestinal bleeding after percutaneous coronary intervention.
    Jiang Z; Wu H; Duan Z; Wang Z; Hu K; Ye F; Zhang Z
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):636-41. PubMed ID: 23684576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis.
    Barkun AN; Bardou M; Pham CQ; Martel M
    Am J Gastroenterol; 2012 Apr; 107(4):507-20; quiz 521. PubMed ID: 22290403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common drugs can harm elderly patients.
    Voelker R
    JAMA; 2009 Aug; 302(6):614-5. PubMed ID: 19671895
    [No Abstract]   [Full Text] [Related]  

  • 39. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
    Shrestha K; Hughes JD; Lee YP; Parsons R
    Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.